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Abstract
Background: Currently, the routine treatment for acute appendicitis in the United Kingdom is an appendicectomy.
However, there is increasing scientific interest and research into non-operative treatment of appendicitis in adults
and children. While a number of studies have investigated non-operative treatment of appendicitis in adults, this
research cannot be applied to the paediatric population. Ultimately, we aim to perform a UK-based multicentre
randomised controlled trial (RCT) to test the clinical and cost effectiveness of non-operative treatment of acute
uncomplicated appendicitis in children, as compared with appendicectomy. First, we will undertake a feasibility
study to assess the feasibility of performing such a trial.
Methods/design: The study involves a feasibility RCT with a nested qualitative research to optimise recruitment
as well as a health economic substudy. Children (aged 4–15 years inclusive) diagnosed with acute uncomplicated
appendicitis that would normally be treated with an appendicectomy are eligible for the RCT. Exclusion criteria
include clinical/radiological suspicion of perforated appendicitis, appendix mass or previous non-operative treatment
of appendicitis. Participants will be randomised into one of two arms. Participants in the intervention arm are treated
with antibiotics and regular clinical assessment to ensure clinical improvement. Participants in the control arm will
receive appendicectomy. Randomisation will be minimised by age, sex, duration of symptoms and centre. Children
and families who are approached for the RCT will be invited to participate in the embedded qualitative substudy,
which includes recording of recruitment consultants and subsequent interviews with participants and non-participants
and their families and recruiters. Analyses of these will inform interventions to optimise recruitment. The main study
outcomes include recruitment rate (primary outcome), identification of strategies to optimise recruitment, performance
of trial treatment pathways, clinical outcomes and safety of non-operative treatment. We have involved children, young
people and parents in study design and delivery.
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Discussion: In this study we will explore the feasibility of performing a full efficacy RCT comparing non-operative
treatment with appendicectomy in children with acute uncomplicated appendicitis. Factors determining success of the
present study include recruitment rate, safety of non-operative treatment and adequate interest in the future RCT.
Ultimately this feasibility study will form the foundation of the main RCT and reinforce its design.
Trial registration: ISRCTN15830435. Registered on 8 February 2017.
Keywords: Appendicitis, Non-operative treatment, Paediatric surgery, Appendicectomy, Feasibility
Background
Acute appendicitis is the most common surgical emergency
in children [1]. The lifetime risk of developing appendicitis
is 7–8%, and the most common age for developing appen-
dicitis is in the early teens. Appendicectomy is considered
the gold standard treatment for acute appendicitis by most
surgeons, but many parents and patients find the prospect
of the need for emergency surgery frightening and one they
are keen to avoid if an alternative is available [2]. Prelimin-
ary work we have already undertaken with children and
families confirms a high level of interest in non-operative
treatment, and indeed a preference for non-operative treat-
ment so long as clinical outcomes are comparable.
Although appendicectomy is considered a simple
procedure, it requires a general anaesthetic and an abdom-
inal operation with its associated risks. The complication
rate of appendicectomy (including wound infection, intra-
abdominal abscess and adhesional small bowel obstruction)
is up to 25% [3], with a need for hospital readmission in 4–
5% of cases [4, 5]. A contemporary estimation of these risks
is available from the National Appendicectomy Audit, a
nationwide audit of outcomes of appendicectomy for acute
appendicitis in 19 specialist paediatric surgery centres in
the United Kingdom [6]. Over a 2-month period, 242 ap-
pendicectomies for acute appendicitis were performed. The
negative (histologically normal) appendicectomy rate was
10.3%, and the 30-day adverse event (AE) rate (a composite
of readmission, re-intervention, pelvic collection and
wound infection) was 15.3%. The economic burden to the
healthcare system of paediatric appendicitis in England is in
excess of £21 million per year and requires significant re-
source use, including need for out-of-hours surgery (45% of
all paediatric appendicectomies were performed between
1800 and 0800 in the National Appendicectomy Audit).
An alternative approach to treating acute appendicitis in
children would be treatment with antibiotics and without
an appendicectomy. Whilst there is growing scientific
interest in the use of non-operative treatment with antibi-
otics owing to its potential benefits over surgery and exist-
ing data to support its safety, the relative efficacy of this
approach compared with appendicectomy is not yet
known [7]. By undergoing a non-operative approach to
treatment of their appendicitis, patients may avoid the
mental and physical stress and trauma of an operation as
well as the associated complications. Non-operative treat-
ment has the potential to reduce the quantity of resources
used by the National Health Service (NHS). For example,
by reducing the amount of theatre time, staff time and
surgical resources used for the treatment of appendicitis,
there could be significant savings for the NHS.
It has been known for some time that acute appendicitis
can be treated successfully by antibiotics alone in the con-
text of remote environments without surgical service cap-
ability [8]. However, the role of non-operative treatment
as primary therapy has only recently come under consid-
eration in developed healthcare systems, initially in adults
[3, 9–15] and more recently in children [16–18]. Although
studies in adults are sometimes extrapolated to children,
to do so is problematic because there are key differences
in appendicitis occurring in adults compared with in
children. The presentation of appendicitis and the intra-
abdominal inflammatory response are different in adults
and children [19, 20] and may be more amenable to
antibiotic treatment alone, and the psychosocial and
economic impact of appendicitis in children affects the
whole family rather than just the individual. Therefore, a
paediatric randomised controlled trial (RCT) is necessary
to compare both treatment options.
There has been just one pilot RCT, recently performed
in Sweden, comparing non-operative treatment with an-
tibiotics with appendicectomy in children with acute
appendicitis [18]. Fifty children (aged 5–15 years) with
acute non-perforated appendicitis were randomised to
antibiotics (n = 24) or appendicectomy (n = 26). All
children in the surgery group had histopathologically
confirmed acute appendicitis, and none experienced a
significant surgical complication. In the antibiotic group,
2 of 24 underwent appendicectomy within the time of
primary antibiotic treatment, and 1 further child
required appendicectomy for histologically proven, re-
current acute appendicitis 9 months later. Of the eligible
participants, the recruitment rate was 40%; the drop-out
rate following treatment allocation was 2% (1 patient);
and no patient was lost to follow-up by 1 year. This pilot
study was not powered sufficiently to compare the efficacy
of antibiotics versus surgery, but it was conducted to in-
form the design of an international, multicentre RCT
which is currently recruiting in non-UK centres [21].
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Our group recently performed a systematic review and
meta-analysis comparing the efficacy of non-operative
treatment and appendicectomy for uncomplicated ap-
pendicitis in children [7]. Whilst there were limitations
related to a lack of RCTs, the existing data support a
position of equipoise between these two treatment
approaches. Neither our review nor any of the contribut-
ing studies [16–18, 22–24] identified any safety concerns
regarding non-operative treatment.
In addition to outcomes of the acute illness, the devel-
opment of recurrent appendicitis is an important consid-
eration in children who receive non-operative treatment
that is not applicable to children treated with appendicec-
tomy. In adults [9–12, 25], the incidence of recurrence
(within 1 year) is around 15%. A recent pilot study of non-
operative treatment of appendicitis in children with 1 year
of follow-up reported a recurrence rate of 5% [18], and
our recent systematic review estimated an incidence of
14% [7]. This is the best current estimate in children.
Given the current uncertainty regarding the relative effi-
cacy and cost-effectiveness of non-operative treatment
compared with appendicectomy in children with uncom-
plicated acute appendicitis, a definitive RCT is necessary.
Although RCTs are ongoing in other countries [26, 27],
there are important differences in diagnostic techniques
and healthcare delivery in the United Kingdom that
mandate a UK-specific trial. These include a much lower
reliance on diagnostic imaging for confirmation of appen-
dicitis in the United Kingdom than in other countries, as
well as a higher negative appendicectomy rate and a lower
uptake of laparoscopic appendicectomy in the United
Kingdom, all of which may influence relative efficacy of
non-operative treatment compared with surgery [6, 28].
Prior to performing a large efficacy trial, we designed this
feasibility study, which includes a feasibility RCT, to in-
form the design and conduct of a future RCT and establish
whether a main trial is possible in the United Kingdom.
Methods/design
Study design
The CONTRACT (CONservative TReatment of Appendi-
citis in Children Trial - feasibility) study comprises the fol-
lowing elements:
1. A randomised controlled feasibility trial of children
comparing a non-operative treatment pathway with
appendicectomy. A standardised treatment pathway
(Fig. 1) will be used in each arm of the study, beginning
with broad-spectrum antibiotics from the point of
enrolment. One arm will then undergo urgent
appendicectomy, while the other will be treated non-
operatively with continuation of broad-spectrum
antibiotics. Both treatment pathways will include the
same follow-up schedule.
2. A detailed programme of embedded qualitative and
quantitative research to optimise recruitment to the
feasibility RCT. It will also inform the design and
conduct of any future RCT of non-operative
treatment versus appendicectomy in the treatment
of acute uncomplicated appendicitis in children.
3. A health economics (HE) feasibility study to allow
the identification of key cost drivers and other
parameters necessary to perform a full economic
evaluation in our future RCT. This will include the
design and piloting of data collection tools and
adoption of a micro-costing approach. A full protocol
of the HE substudy is described separately.
4. The development of a core outcome set (COS) for
the non-operative treatment of children with
uncomplicated acute appendicitis for use in the future
RCT as well as in the wider research community. A
full protocol for the COS is published elsewhere [29].
5. A patient and public involvement (PPI) work stream
that reciprocally feeds into elements 1, 2 and 4 above.
We have formed a study-specific advisory group (SSAG)
made up of children who have had acute uncomplicated
appendicitis, children who have not, and parents.
Randomised controlled feasibility trial
Population The sample population will comprise children
aged 4–15 years inclusive with a clinical diagnosis of acute
appendicitis who would normally be treated with an appen-
dicectomy as part of their standard care. Patients will be
identified by the clinical team at the time of diagnosis, and
their eligibility will be confirmed by the research team as
soon as possible.
Inclusion criteria
 Children aged 4–15 years (> 3 and < 16 years)
 Clinical diagnosis, either with or without
radiological assessment, of acute appendicitis which
prior to study commencement would have been
treated with appendicectomy
 Written informed parental consent, with child
assent if appropriate
Exclusion criteria
 Clinical signs or radiological findings to suggest
perforated appendicitis
 Presentation with appendix mass
 Previous episode of appendicitis or appendix mass
treated non-operatively
 Major anaesthetic risk precluding allocation to the
appendicectomy arm
 Known antibiotic allergy preventing allocation to
non-operative treatment arm
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 Antibiotic treatment started at referring institution
(defined as two or more doses administered)
 Cystic fibrosis
 Positive pregnancy test
 Current treatment for malignancy
Randomisation Eligible patients will be identified,
approached and consented by the treating clinician. After
written informed consent is obtained, a member of the
trial team on-site will randomise the participant to one of
two treatment groups in a 1:1 ratio via an independent
web-based system (Trans European Network for Clinical
Trials Services [TENALEA]). This online system allows
complete pre-randomisation concealment of treatment
allocation and provides instant assignment to either the
appendicectomy or non-operative treatment group. Mini-
misation will be used to account for recruiting centre and
ensure balance between the groups in factors that may
affect diagnostic accuracy and outcome of treatment. The
factors which are taken into account are (1) sex (male or
female), (2) aged 4–8 or 9–15 years, (3) duration of symp-
toms (onset of pain to recruitment into study < 48 h or
≥ 48 h) and (4) recruiting centre.
Interventions
Non-operative treatment group The treatment path-
way in the non-operative treatment group will comprise
NBM = nil by mouth
† non-operative treatment = NBM/sips for initial 12h minimum then advance diet as tolerates; iv antibiotics 24h minimum, 
change to oral once afebrile for 24h, total course 10 days; analgesia
* appendicectomy group – no routine use of nasogastric tube or urinary catheter, advance diet as tolerates
$ defined as either seeing a hole in the appendix or faecal matter/faecolith in the peritoneal cavity
$$ continue iv antibiotics until afebrile for 24h, then change to oral; minimum 5 days total antibiotics
** criteria for discharge include: vital signs within normal limits, tolerating light diet, adequate oral analgesia, mobile
Inclusion criteria met
Study explained, informed consent
Randomisation
Appendicectomy Non-operative treatment†
NBM, broad spectrum antibiotics
NBM, broad spectrum antibiotics, 
regular clinical review
Review at 24 hours following 
randomisation
Clinical deterioration Stable / improved
Continue non-operative 
treatment†
Review at 48 hours following 
randomisation
No improvement Improvement 
Proceed to appendectomy
Post-operative antibiotics per institutional 
guidelines
Guidance
normal appendix or non-perforated 
appendicitis – no further antibiotics
perforated appendicitis$ – minimum 3 days iv 
$$
Assess for discharge**
Continue non-operative 
treatment†
Clinical deterioration? Investigate 
and treat as appropriate
Stable / improvedClinical deterioration
Assess for discharge**
antibiotics
Fig. 1 Clinical pathway for both treatment arms
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fluid resuscitation, a minimum of 24 h of broad-
spectrum intravenous (IV) antibiotics (per local policies),
a minimum of 12 h of nil by mouth (NBM) and regular
clinical review to detect signs and symptoms of signifi-
cant clinical deterioration, including but not limited to
increasing fever, increasing tachycardia, and increasing
tenderness. After the initial 12 h period of NBM, oral
intake will be advanced as tolerated. Children success-
fully treated without an operation will be converted to
oral antibiotics once they are afebrile for 24 h and
tolerating oral intake (per local policies and after the
minimum 24 h broad-spectrum IV antibiotics).
Clinical reviews will also be completed at approxi-
mately 24 h and 48 h post-randomisation. Any children
who show signs of significant clinical deterioration by 24
h or at any point during the trial will undergo appendi-
cectomy. Children who are considered stable or improv-
ing will continue with non-operative treatment. At 48 h,
any children who have not shown clinical improvement
will also undergo appendicectomy. The decision to con-
tinue non-operative treatment at these time points or to
recommend discontinuation of non-operative treatment
and appendicectomy will be made by the treating con-
sultant and based on clinical judgement rather than on
any specific features that are not evidence-based. All rea-
sons for change in treatment will be recorded in detail.
Any children who receive an appendicectomy for an
incomplete response to non-operative treatment will fol-
low a standardised post-operative treatment regimen
already in use at each institution and identical to that
used in the appendicectomy arm. The reason for having
an appendicectomy will be recorded.
Appendicectomy group Children randomised to the
appendicectomy arm will undergo either open or laparo-
scopic appendicectomy at the surgeon’s discretion, per-
formed by a suitably experienced trainee (as per routine
current practice) or a consultant. A peritoneal micro-
biology swab will be taken at the time the peritoneum is
first opened or from the appendix, and from any peri-
toneal fluid sent for microbiological culture. The results
of this swab will be recorded.
Patients will receive IV antibiotics from the time of
randomisation and be treated post-operatively with IV an-
tibiotics according to existing institutional protocols; how-
ever, the following recommended regimen is used to guide
practice: children with acute uncomplicated appendicitis
or a macroscopically normal appendix will receive no fur-
ther antibiotics. Children with a perforated appendix (de-
fined as a faecolith or faecal matter within the peritoneal
cavity, or visualisation of a hole in the appendix) will con-
tinue to receive IV antibiotics for a minimum of 3 days
and will receive a minimum total course of antibiotics of 5
days (IV and oral). It is not possible to standardise the
duration of antibiotic therapy, owing to anticipated vari-
ation in intra-operative findings and in response to treat-
ment. The types of antibiotics used will be identical to
those used in the non-operative treatment arm within
each centre. Any child failing to respond to these first-line
antibiotics will be treated as is clinically appropriate with a
longer course of antibiotics or a change in antibiotic ther-
apy, with the choice of antibiotic determined by intra-
operative swab or fluid culture.
Post-operatively, children with uncomplicated acute
appendicitis or a normal appendix will not routinely
have a nasogastric tube or a urinary catheter. They will
receive oral intake as tolerated after surgery.
Discharge assessment Criteria for discharge to home
will be identical to those in both treatment groups and will
be as follows: vital signs within normal limits for age,
afebrile for ≥ 24 h, tolerating light diet orally, adequate
oral pain relief and be mobile. Patients being treated non-
operatively will receive a total course of 10 days of antibi-
otics following randomisation, unless decided otherwise
by the clinician. If more than 10 days of oral antibiotics
are administered, this will be recorded (including reason).
Children who receive non-operative treatment will not
routinely be offered interval appendicectomy, but they will
be counselled about the risk of recurrence using best
available data.
Once a decision to discharge the child has been made,
a member of the clinical team who has not been in-
volved directly in the child’s treatment will be asked to
complete a discharge assessment. This assessor will not
have prior knowledge of the randomisation or treatment
received by the child. Upon completion of the discharge
assessment, they will “guess” which treatment the child
received. If the assessor should become unblinded dur-
ing the assessment, this will also be recorded. Through
this we hope to be able to determine the feasibility of a
blinded discharge assessment in a future RCT.
Follow-up Follow-up appointments for all participants
will take place at 6 weeks and at 3 and 6 months following
discharge, either in the outpatient clinic or in the clinical
research facility at each centre. If a face-to-face appoint-
ment is not possible, the 3- and 6-month follow-up can be
completed over the phone. Data on resource use, time to
return to daily activities and recurrent appendix-related
problems (including unexplained abdominal pain and
recurrence) will be collected prospectively to ensure high
accuracy. The schedule of enrolment, intervention and
follow-up is shown in Fig. 2.
Primary outcome The primary outcome is assessment
of whether it is feasible to conduct a multi-centre RCT
testing the effectiveness and cost-effectiveness of a
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non-operative treatment pathway for the treatment of
acute uncomplicated appendicitis in children. This will be
evaluated as the proportion of eligible patients who are
approached and recruited to the study over 12 months.
Secondary outcomes The following secondary outcomes
are centred predominately on the qualitative and COS sub-
studies contributing to the development of a future RCT:
1. Willingness of parents, children and surgeons to take
part in a randomised study comparing operative
versus non-operative treatment and identify anticipated
recruitment rate. This will be assessed from audio-
recorded family-surgeon recruitment consultations;
interviews with patients, parents, surgeons and nurses;
surgeon surveys; and focus groups.
2. Identification of strategies to optimise surgeon-
family communication using the above consultation
and interview data.
3. Design of a future RCT from the perspectives of
stakeholders at participating sites (e.g., children,
parents, surgeons, nurses) informed by the consultation
and interview data, surgeon surveys and focus groups.
4. Assessment of the equipoise and willingness of UK
paediatric surgeons to participate in a future RCT
through surgeon surveys and focus groups.
5. Clinical outcomes of trial treatment pathways,
including the following:
a. Overall success of initial non-operative treatment
(measured as the number of patients randomised to
non-operative treatment, discharged from hospital
without appendicectomy)
b. Complications of disease and treatment (measured
during hospital stay and 6-month follow-up period)
c. Rate of recurrent appendicitis during 6-month
follow-up period
6. Performance of study procedures including retention of
participants for the duration of the study, and feasibility
of outcome recording and data collection systems.
Sample size calculations The study will recruit partici-
pants from three centres for 12 months. Each centre treats
80–100 children per year with acute appendicitis, with an
estimate that at least 130 will be eligible out of the 240–
300 potential patients. Assuming that 40–50% will be
recruited (i.e., 52–65 participants in feasibility RCT), we
will be able to estimate a true 40% recruitment rate with a
95% CI of 31–49% and a true 50% recruitment rate with a
95% CI of 41–59%. A total of 52–65 participants in the
feasibility RCT will be adequate to test treatment pathway
procedures, data collection methods and loss to follow-up.
For the embedded qualitative work related to recruitment,
we will recruit until we reach data saturation, which we
estimate will entail analysing approximately 40 recruit-
ment consultations, 20–30 family interviews and 20–25
healthcare professional interviews.
Clinical trial data analysis Data analysis will be per-
formed by the study statistician, who will be blinded to
treatment allocation by the use of coded data as per the
STUDY PERIOD
Enrolment Baseline Allocation Post-allocation Close-out
TIMEPOINT 0 0 0 Inpatient Discharge 2weeks 6weeks 3months 6months
ENROLMENT:
Eligibility screen X
Informed consent X
Treatment allocation X
INTERVENTIONS:
Non-operative 
treatment (Arm A)
Appendicectomy
(Arm B)
ASSESSMENTS:
Diagnostic tests (if any 
completed) X
Medical History X
Physical Exam and 
Vital Signs X X
Safety Assessments X X
Antibiotic and Pain 
Medication Use X X
AEs X X X X X X X X
Recurrent Appendicitis
(Arm A Only) X X X
Surgical 
Complications
(Arm B Only)
X X X X X
HE Data collection X X X X X X
Qualitative Sub-Study X X
Fig. 2 Standard Protocol Items: Recommendations for Interventional Trials (SPIRIT) checklist: patient schedule of procedures. AE Adverse event, HE
Health economics
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statistical analysis plan. Because this is a feasibility study,
all analyses will be treated as preliminary and explora-
tory and will be mainly descriptive. Feasibility outcomes
(number of eligible patients, recruitment/retention rates,
reasons for non-participation, success of blinding of the
discharge assessor), treatment outcomes and complica-
tions will be presented by simple summary statistics with
95% CIs. Clinical outcome measures will be compared
between treatment groups in an exploratory analysis,
and variability estimates will be used to inform the
sample size for a future definitive trial. The study will be
reported in accordance with the Consolidated Standards
of Reporting Trials (CONSORT) 2010 statement.
Trial oversight and safety monitoring A study man-
agement group (SMG) will be responsible for overseeing
the day-to-day management of the trial. A trial steering
committee (TSC) and data and safety monitoring com-
mittee (DSMC) will also share independent oversight of
the study. The DSMC will review the trial and its data
from a safety and ethical perspective and will make
recommendations regarding the continuation of the trial
to the TSC, who will make the ultimate decision. The
roles and responsibilities of each committee are detailed
in a separate charter. The SMG will provide feedback to
the SSAG and vice versa.
Any patient who does not complete the non-operative
treatment pathway within the trial (i.e., deteriorates or
does not improve) and undergoes appendicectomy will
be reported to the trial manager (TM) within 48 h of ap-
pendicectomy. The TM will inform the TSC chairperson
and convey the clinical data relating to this patient. The
TSC chair will hold responsibility for determining
whether to ask the DSMC to meet and review the data
from that patient. The DSMC will subsequently advise
the TSC on their findings, including an assessment of
whether it is acceptable to continue to recruit patients.
Qualitative substudy
The embedded qualitative substudy comprises audio re-
cordings of recruitment consultations between patients,
their families and recruiters (paediatric surgeons and
research nurses), as well as follow-up interviews with pa-
tients, their families and recruiters about their experi-
ences of recruitment and the trial. Focus groups will also
be conducted with paediatric surgeons at non-study sites
about their views of the trial. When patients are
approached about the study, they will be asked for verbal
consent to audio-record the discussion. Seeking written
consent for the audio recording at this point would
distract from the focus of the consultation; therefore, we
will ask patients at the end of the consultation for writ-
ten consent to keep the recording and use it for analysis.
After discharge, a trained qualitative researcher will
contact and invite patients and their families to be inter-
viewed either in their homes or by telephone. Recruiters
will also be invited to be interviewed either in their place
of work or by telephone. All consultations and inter-
views will be digitally audio-recorded and uploaded for
transcription by a professional transcription service and
pseudo-anonymised before analysis.
Analysis of recruitment consultations Analyses of the
recruitment consultations will use both the recordings
and transcripts to document the interactions between
recruiters and families, explore information provision
and use of communication techniques, as well as inter-
vention preferences and trial participation decisions. If
analyses of the audio-recordings suggest that recruit-
ment difficulties are potentially linked to communication
during the recruitment consultation, this information
will be fed back to the local principal investigators so
that training of recruiters can be implemented immedi-
ately. The equipoise and views of healthcare profes-
sionals recruiting to the trial will also be assessed, as
well as the key ways in which their views differ from
non-participating surgeons.
The analyses will also draw upon content analytic
methods to describe what was said by whom and how
often in the audio recordings of recruitment sessions.
Constant comparison methods will also inform identifi-
cation of common or divergent themes, particularly
focusing on the impact of statements by the recruiter on
parent responses and views. This will focus on key
sections of the transcripts, such as when randomisation
is offered. The percentage of eligible patients recruited
will be documented using site screening logs, noting any
families who decline randomisation or do not accept the
randomised allocation.
Analysis of interview and focus group data The
findings derived from the analysis of the recruitment
consultations will be linked with qualitative data from
the interviews where patients discuss the acceptability of
trial methodology to determine the feasibility and
acceptability of a full trial, and also with the recruiter in-
terviews. Analysis of interview and focus group data will
draw on the principles of the constant comparative
method and thematic analysis. One member of the
research team will lead a process of ‘cycling’ between
the developing analysis and new data. Other members of
the qualitative study team (including at least one
surgeon) will develop and test the analysis by periodic
discussion and independent analyses of a proportion of
transcripts to compare coding and findings.
Initially, each transcript will be read several times by
the lead analyst before development of open codes to
describe each relevant unit of meaning, although coding
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will occur at multiple levels, from detailed descriptions
of communication and experiences of the trial, to the
general orientation of participants towards clinical
research. Through comparison within and across the
transcripts, the open codes will be developed into cat-
egories to reflect and test the developing analysis. The
categories will be organised into a framework to code
and index the transcripts using NVivo software (QSR
International, Doncaster, Australia). The framework
categories will continually be checked and modified to
ensure an adequate ‘fit’ with the data, whilst also
accounting for variation in the data and ‘deviant’ cases.
A second member of the team will check the categories
and the assignment of data to them. Our analytic
approach will be informed by writings on quality in
qualitative research [30].
Patient and public involvement
We recognise that PPI is a crucial element of this study,
and as such, we will form a SSAG made up of parents,
children and young people, some of whom will have ex-
perience of treatment for acute uncomplicated appendi-
citis. This group will provide overarching consultation and
collaboration functions for the programme of research,
minus the HE substudy. The group will help devise patient
and parent documentation (including but not limited to
information sheets, consent forms and a recruitment
video) and provide insight on the qualitative substudy
interview schedule and COS development. They will also
help with the dissemination of the results back to study
participants via information sources accessed by children,
young people and parents and through a variety of media.
Discussion
Progression to main trial
Through this initial study we aim to inform the design,
conduct and feasibility of a future efficacy RCT whilst
confirming for the first time the safety of non-operative
treatment in UK paediatric surgical centres. The decision
to progress to a future RCT will be based on a combin-
ation of recruitment rate achieved, safety of non-operative
treatment and adequate surgeon interest. These issues will
be discussed by the trial management and oversight
groups and be reviewed by a new funding panel. Cur-
rently, we think that a future main RCT will be considered
feasible if the following goals are met:
1. The lower boundary of the 95% CI of the recruitment
rate is above 20%.Whilst it is likely there are adequate
patients to complete a study in which the recruitment
rate is less than 20%, this is interpreted as lack of
patient interest in non-operative treatment or, poten-
tially, concerns about the trial and associated
treatment.
2. The DSMC does not stop the trial on safety
grounds. If the DSMC chooses to stop the trial, the
non-operative treatment pathway will have to be
reconsidered before a future RCT is planned.
3. Adequate surgeons and centres can be identified
that are required to achieve target recruitment. On
the basis of the current sample size estimate, five to
ten UK paediatric surgery centres are required to
make a future RCT feasible.
Specific ethical considerations
1. Participants will be randomised to a novel care
pathway, which, although in use at a number of
institutions worldwide, has not been rigorously
tested to assess efficacy and safety in participating
centres. Although existing literature proposes that
the non-operative pathway is safe [7, 16, 24], pa-
tients and their families will be informed that the
clinical outcomes are being investigated as part of
the study. Clinical reviews have been incorporated
into the treatment pathways to minimise risk and/or
complications of unsuccessful treatment.
2. Although written informed consent will be given by
the parent or guardian, the child will be given age-
appropriate information about the study and may
confirm their assent during the completion of the
consent form if they wish to do so. Consent will be
taken by a member of the surgical team who has ex-
perience recruiting children to research studies and
has completed appropriate good clinical practice
training. A copy of the study consent form is included
with the study protocol (see Additional file 1).
3. Owing to the urgency associated with the treatment
of appendicitis, the period for taking consent will be
short to ensure that the research process does not
impede upon the provision of safe and effective care,
but it does allow sufficient time for patients and
their family to make an informed decision about the
trial.
Some patients/parents may be concerned that delay in
appendicectomy may increase the rate of perforation
and AEs. However, this is not borne out by the literature
on large numbers of adult [31] and paediatric patients
[31–35], and participants will be counselled accordingly.
Following treatment, children in the non-operative
treatment group will theoretically continue to be at risk
of recurrence of appendicitis. Whilst the risk of recur-
rence is low, the children and their families will be fully
informed of this risk. We will seek permission from
these families to hold their personal details in a secured
registry and to contact them in the future to determine
if they have had a recurrence.
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Trial status
This study protocol describes version 2, dated 10 April
2017. The study opened to recruitment on 1 March
2017 and will recruit patients for a period of 12 months
until 28 February 2018 at three paediatric surgical teach-
ing hospitals in England: Alder Hey Children’s Hospital,
Liverpool; Southampton Children's Hospital, Southamp-
ton; and St. George’s Hospital, London.
Additional files
Additional file 1: Parental consent form with optional patient assent.
(DOC 136 kb)
Additional file 2: SPIRIT checklist. (DOC 123 kb)
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